- Poster presentation
- Open Access
- Published:
Dexmedetomidine ameliorates gut lactate production and impairment of exogenous lactate clearance in an endotoxic sheep model
Intensive Care Medicine Experimental volume 3, Article number: A414 (2015)
Introduction
The mechanisms of persistent hyperlactemia during endotoxic shock are probably multifactorial. Both hypoperfusion-related anaerobic production and adrenergic-driven aerobic generation have been implicated. More recently an early and severe impairment in exogenous lactate clearance has also been described [1]. Theoretically, an excessive adrenergic response could influence all these mechanisms and thus aggravate the problem.
Objectives
To assess the effects of dexmedetomidine (DEX) on lactate production and exogenous lactate clearance in an endotoxic shock model.
Methods
Twelve anesthetized sheep were subjected to a multimodal hemodynamic/perfusion assessment including hepatic and portal vein catheterizations, total hepatic blood flow, sublingual microcirculation, and muscle microdialysis. After the monitoring phase, all received a 5 mcg/kg LPS bolus (E coli O127:B8®) and then 4 mcg·kg1·hr1 for the rest of the experiment. After 1hr they were volume resuscitated, and then randomized to placebo or DEX. Sampling and exogenous lactate clearances [2] were performed at 4 points (figure 1).

Figure 1
Results
DEX was not associated with any adverse hemodynamic effect in terms of cardiac output, heart rate, mixed venous oxygen saturation, central venous-arterial pCO2 gradient and NE requirements as compared to placebo. DEX animals presented significant lower epinephrine levels (4.6 ± 1.3 vs 7.1 ± 1.4 ng/ml), arterial lactate levels (6.4 ± 3.1 vs 9.2 ± 1.8 mmol/l), portal vein lactate levels (6.2 ± 2.2 vs 8.1 ± 2.0 mmol/l); and higher portal vein O2 saturations (78 ± 16 vs 68 ± 11 %), and exogenous lactate clearance (7.2 ± 5.4 vs 2.9 ± 1.5 ml/kg/min) as compared to placebo at point D. No differences in muscle lactate production or sublingual microcirculatory parameters could be observed.
Conclusions
Dexmedetomidine ameliorates the increase in gut lactate production and impairment of exogenous lactate clearance in experimental endotoxic shock. This effect is associated with a significant reduction in systemic epinephrine levels.
Grant Acknowledgment
FONDECYT 1130200, Chile
References
Tapia P, Soto D, Bruhn A, Regueira T, Jarufe N, Alegria L, et al: 0101. Early and severe impairment of lactate clearance in endotoxic shock is not related to liver hypoperfusion: preliminary report. Intensive Care Medicine Experimental. 2014, 2 (Suppl 1): P12
Levraut J, Ciebiera JP, Chave S, Rabary O, Jambou P, Carles M, Grimaud D: Mild hyperlactatemia in stable septic patients is due to impaired lactate clearance rather than overproduction. Am J Respir Crit Care Med. 1998, 157: 1021-1026.
Author information
Authors and Affiliations
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
About this article
Cite this article
Hernandez, G., Tapia, P., Ospina-Tascón, G. et al. Dexmedetomidine ameliorates gut lactate production and impairment of exogenous lactate clearance in an endotoxic sheep model. ICMx 3 (Suppl 1), A414 (2015). https://doi.org/10.1186/2197-425X-3-S1-A414
Published:
DOI: https://doi.org/10.1186/2197-425X-3-S1-A414
Keywords
- Dexmedetomidine
- Endotoxic Shock
- Epinephrine Level
- Sublingual Microcirculation
- Arterial Lactate Level